NT5C1A and inclusion body myositis: Therefore, to understand the clinical utility of the anti-NT5c1A autoantibody in the diagnosis of IBM, we measured the anti-NT5c1A autoantibody in inflammatory myopathies and analyzed the clinicopathological features.